BioMicro Seeks $10M Series B to Launch Novel Microfluidics Platform | GenomeWeb

WASHINGTON, DC, Oct. 4 – Fledgling microfluidic firm BioMicro said on Thursday that it hopes to close a Series B round of financing worth $10 million by the end of the year.

Michael McNeely, president and CEO of the Sandy, Utah-based company, told GenomeWeb that the capital will help BioMicro commercialize its novel microfluidics platform, the Micro Array User Interface, or MAUI.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.